Analyst Research: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

103.10USD
22 Aug 2014
Price Change (% chg)

$-0.39 (-0.38%)
Prev Close
$104.19
Open
$103.60
Day's High
$104.03
Day's Low
$102.97
Volume
1,710,710
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Our Economy without Stimulus; forward observations. 22 Aug 2014 Stock Traders Daily 102 20.00
Thomson Reuters Stock Report - JOHNSON & JOHNSON (JNJ-N) 22 Aug 2014 Thomson Reuters Stock Report 12 25.00
Trading Report for (JNJ). A detailed report, including free correlated market analysis, and updates. 22 Aug 2014 Stock Traders Daily 10 20.00
JNJ: Due Diligence Review: Forensic Earnings and Valuation 21 Aug 2014 New Constructs, LLC 9 25.00
Is Johnson & Johnson the Safe Haven Investors Seek? 19 Aug 2014 Sadif Analytics (Premium) 12 25.00
"The Economy Matters" Report for JNJ: the economy's impact on JNJ's price and risk, featuring the powerful Economic Climate Rating 18 Aug 2014 MacroRisk Analytics/EconomicInvestor 7 25.00
ValuEngine Rating and Forecast Report for JNJ 17 Aug 2014 ValuEngine, Inc. 11 25.00
Johnson & Johnson 16 Aug 2014 S&P Capital IQ – STARS Reports 11 127.00
JNJ.N - Event Transcript of Johnson & Johnson conference call, Jul. 15, 2014 / 8:30AM ET 15 Jul 2014 Thomson Reuters StreetEvents 31 75.00
 
Name Age Since Current Position

Alex Gorsky

54 2012 Chairman of the Board, Chief Executive Officer

Dominic Caruso

56 2007 Chief Financial Officer, Vice President - Finance

Sandra Peterson

55 2012 Group Worldwide Chairman

Paulus Stoffels

52 2012 Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group

Michael Ullmann

55 2012 Vice President, General Counsel
Search Stocks